#Focusing #production #deep #brain #stimulation #systems #Jingyu #Medical #completed #million #yuan #financing
It is reported that “Jingyu Medical” has recently completed a series D financing of more than 100 million yuan. This round of financing was led by Yanchuang Capital, followed by institutions such as Deyi Capital, Tahoe Capital, and Shanghai Yehao. The raised funds will be mainly used for the development of the company’s existing deep brain stimulation products under research, clinical trials for new indications, marketing and commercialization of the product line on the market, and will continue to provide more overall solutions for clinical treatment in the future , To better benefit the majority of patients in domestic Parkinson and other fields.
“Jingyu Medical” was founded in 2009. It is an innovative high-tech medical device company integrating R&D, production and sales of deep brain stimulation systems. It has complete independent intellectual property rights and continuously develops new technologies and products. The company has so far applied for more than 200 patents, including 10 international patents. In terms of team, “Jingyu Medical” has a senior management team composed of core technology experts of deep brain stimulation system, production experts, and company operation experts. These experts have accumulated rich experience after years of work in related fields at home and abroad. . At present, the team members are mainly composed of top students who graduated from famous universities such as Tsinghua University, Peking University, Fudan University, and Jiaotong University.
SR1101 rechargeable implantable deep brain stimulation kit
A breakthrough clinical effect in drug detoxification
According to reports, starting in 2012, “Jingyu Medical” and the team of Professor Gao Guodong of the Air Force Military Medical University have developed a brain-computer chip for drug rehabilitation and a brain pacemaker system for drug rehabilitation based on the addiction mechanism. This worldwide problem. So far, a single-center drug detoxification clinical trial has been completed and a breakthrough treatment effect has been achieved. This result has been published in the international industry authoritative journal “Brain Stimulation”. In addition, this product was approved by the State Food and Drug Administration for “Innovative Green Channel” in 2017. The brain pacemaker for drug detoxification is the world’s first medical device for the treatment of drug addiction and mental illness with the combined regulation of multiple targets in the brain.
Early clinical trial data showed that Jingyu’s brain pacemaker for drug addiction can effectively reduce the psychological cravings of drug addicts, thereby greatly reducing the relapse rate, and is expected to achieve true drug addiction withdrawal. At present, Jingyu’s brain pacemaker is undergoing a national multi-center clinical trial with strict standards (prospective, multi-center, double-blind, and randomized controlled), and its therapy has been further verified. Participating units include: Tangdu Hospital Affiliated to Air Force Military Medical University, China Institute of Drug Dependence of Peking University, Ruijin Hospital Affiliated to Shanghai Jiaotong University, West China Hospital Affiliated to Sichuan University, Nanfang Hospital Affiliated to Southern Medical University.